Xoc Pharmaceuticals is an early-stage, biopharmaceutical company focused on the development of innovative therapeutics. The Company designs novel products “from the ground up” by leveraging information on existing compounds with established pharmacological and clinical history and using its proprietary design and development process to address unmet medical needs, primarily in the CNS disease space. Xoc’s initial product programs are in migraine prevention and Parkinson’s disease maintenance.